Navigated to Fresh Day Meds: GLP-1 Costs, Billing and Commitment
Skip to main content
GLP1 Buyer Guide
All ranked programsProvider profile
Compounded products2 recorded medications

Fresh Day Meds

Fresh Day Meds is recorded on 6 offers in this comparison, covering semaglutide, tirzepatide. Each plan is recorded separately with its own charge, cadence and commitment.

By Open Water Rx Editorial Team, Publisher and buyer-guide research

Price sources checked
Buyer Guide ScoreMethod
72.5/100
Strong

Ranked 37 of 67 programs in the buyer guide index.

Price100/100
Fee transparency50/100
Cadence certainty100/100
Terms on record100/100

Each criterion is rated on its own out of 100. The headline score is the publisher’s overall judgment; it is not an average of these four readings.

Tirzepatide
$179Lowest of 3 recorded plans
Semaglutide
$140Lowest of 3 recorded plans
Membership
Not statedNot stated on the provider page
Commitment
Auto-renewsThe term recorded on the plan

Supported tradeoffs

The dated subscription terms provide exact day-based billing despite monthly/quarterly labels on product cards. The $299 headline rounded to $99/month and $469 to $156/month must not replace full charges or actual cadence. Price lock applies only to the same eligible active plan.

Billing and cancellation

Current new-enrollment one-month plans renew every 23 days; three-month plans renew every 83 days. Semaglutide: $140/23 days, $299/83 days new to GLP-1, $385/83 days transfer. Tirzepatide: $179/23 days, $420/83 days new, $469/83 days transfer.

Availability

The supported-state list is not established for this program, so the field is left blank rather than assumed.

Availability is set program by program by prescriber licensure, pharmacy fulfillment and state rules, so it can change after a directory is published. A provider state directory is not a fulfillment guarantee, and where a supported-state list is not established the field is left blank rather than assumed.

Offer terms in detail

Every field the record carries for each plan, with the date the provider page behind it was checked.

SemaglutideCompounded · not FDA-approved

Marketed one-month plan; 23-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$140

Recurring

Formulation
Compounded injectable
Initial payment
$140 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed one-month treatment plan; actual supply determined by prescription
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Limitations
The dated subscription terms provide exact day-based billing despite monthly/quarterly labels on product cards. The $299 headline rounded to $99/month and $469 to $156/month must not replace full charges or actual cadence. Price lock applies only to the same eligible active plan.
Offers excluded from this release
["Older grandfathered prices and conditional outcome guarantees are not used as current offer prices."]
Verification
published price and billing terms · recheck due October 29, 2026
SemaglutideCompounded · not FDA-approved

New to GLP-1: marketed three-month plan; 83-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$299

Recurring

Formulation
Compounded injectable
Initial payment
$299 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed three-month plan; supply is separate from charge interval
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Example schedule 0.22/0.44/0.88 mg
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Verification
published price and billing terms · recheck due October 29, 2026
SemaglutideCompounded · not FDA-approved

Transfer: marketed three-month plan; 83-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$385

Recurring

Formulation
Compounded injectable
Initial payment
$385 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed three-month plan; supply is separate from charge interval
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Provider determines dose from current prescription; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

Marketed one-month plan; 23-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$179

Recurring

Formulation
Compounded injectable
Initial payment
$179 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed one-month treatment plan; actual supply determined by prescription
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

New to GLP-1: marketed three-month plan; 83-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$420

Recurring

Formulation
Compounded injectable
Initial payment
$420 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed three-month plan; supply is separate from charge interval
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Example schedule 2.2/4.4/6.6 mg
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

Transfer: marketed three-month plan; 83-day renewal

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$469

Recurring

Formulation
Compounded injectable
Initial payment
$469 · Full-price authorization at checkout; treatment capture after physician approval. Later automatic payments follow the explicit 23/83-day schedule.
Billing cadence
Recurring
Supply period
Marketed three-month plan; supply is separate from charge interval
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Conditional fees
Conditional $75 consultation fee for initial cancellation/refusal/nonresponse after documented clinical work. A successful renewal includes a $75 consultation allocation; do not add it to the advertised charge.
Inclusions
Provider care, prescribed medication, injection supplies, ongoing support and expedited shipping.
Dose scope
Provider-reviewed standard options through 15 mg weekly
Eligibility
Subject to provider approval and availability
Cancellation
Confirm pause or cancellation through portal Billing Management/Tickets before the charge is processed. Merely opening a ticket does not stop billing. Indefinite pause has no automatic restart; cancellation requires a new checkout to restart at then-current prices.
Refunds
Initial medical ineligibility releases authorization without consultation charge. Voluntary cancellation/refusal after clinical work begins incurs $75; nonresponse requires a final notice of at least 24 hours. Approved/current orders are not guaranteed refundable. On paid renewals $75 is a consultation allocation retained from any courtesy refund, not an extra charge.
Verification
published price and billing terms · recheck due October 29, 2026

Cost and verification scope

Semaglutide · Tirzepatide

Published standard plan bundle; conditional charges are described in provider terms

Published pricing and billing terms; no purchase, clinical, licensing or fulfillment audit

Last checked

Most recent check date

October 22, 2026

The newest date we checked Fresh Day Meds's own published pages. A figure we could not check carries no date rather than an unverified one, and this research reads published pages, not checkout transactions.

How sources are checked

Every recorded offer, side by side with the others: the comparison ledger.

Back to the provider directory
FAQ

Questions about Fresh Day Meds

How to read the fields, the sources and the labels on this profile.

  • It means no reliable figure exists yet for that field on this provider, so we leave it blank instead of guessing. A field becomes a published value only when a page on this provider supports it.

Last modified . Facts carry the date we checked the provider page behind them.